| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 582 | 1.795 | 661 | 1.373 | 426 | 922 | 5.769 | 7.914 | 5.875 | 6.122 |
| Total Income - EUR | 582 | 1.795 | 661 | 1.373 | 426 | 922 | 5.774 | 7.914 | 5.903 | 6.122 |
| Total Expenses - EUR | 215 | 6 | 0 | 384 | 127 | 0 | 962 | 569 | 2.080 | 8.517 |
| Gross Profit/Loss - EUR | 367 | 1.789 | 661 | 989 | 299 | 922 | 4.812 | 7.346 | 3.823 | -2.395 |
| Net Profit/Loss - EUR | 349 | 1.735 | 641 | 948 | 286 | 910 | 4.758 | 7.107 | 3.300 | -2.395 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Introlife Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.028 | 3.389 |
| Current Assets | 412 | 2.281 | 947 | 1.777 | 1.888 | 2.774 | 5.387 | 7.328 | 2.771 | 1.543 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 372 | 365 | 0 | 0 | 0 | 3.812 | 0 | 0 |
| Cash | 412 | 2.281 | 575 | 1.411 | 1.888 | 2.774 | 5.387 | 3.516 | 2.771 | 1.543 |
| Shareholders Funds | 394 | 2.126 | 694 | 1.629 | 1.883 | 2.758 | 5.327 | 7.070 | 6.709 | 4.277 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18 | 155 | 253 | 148 | 5 | 16 | 59 | 259 | 89 | 656 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8569 - 8569" | |||||||||
| CAEN Financial Year |
8560
|
|||||||||
Comments - Introlife Med S.r.l.